Glen Santangelo
Stock Analyst at Jefferies
(2.51)
# 2,401
Out of 4,984 analysts
79
Total ratings
47.06%
Success rate
2.69%
Average return
Main Sectors:
Stocks Rated by Glen Santangelo
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| HQY HealthEquity | Maintains: Buy | $130 → $134 | $92.28 | +45.21% | 6 | Sep 3, 2025 | |
| TDOC Teladoc Health | Maintains: Hold | $10 → $8 | $7.90 | +1.27% | 7 | Apr 21, 2025 | |
| ANIP ANI Pharmaceuticals | Initiates: Buy | $80 | $95.36 | -16.10% | 1 | Mar 14, 2025 | |
| VTRS Viatris | Maintains: Buy | $15 → $13 | $9.62 | +35.14% | 4 | Mar 7, 2025 | |
| WAY Waystar Holding | Initiates: Buy | $51 | $38.59 | +32.16% | 1 | Feb 11, 2025 | |
| XERS Xeris Biopharma Holdings | Reiterates: Buy | $4 → $6 | $7.67 | -21.77% | 2 | Jan 29, 2025 | |
| NVST Envista Holdings | Maintains: Hold | $20 → $22 | $20.98 | +4.86% | 1 | Jan 23, 2025 | |
| XRAY DENTSPLY SIRONA | Downgrades: Hold | $30 → $20 | $13.43 | +48.92% | 2 | Jan 23, 2025 | |
| PCRX Pacira BioSciences | Maintains: Buy | $15 → $18 | $26.07 | -30.96% | 5 | Sep 24, 2024 | |
| PGNY Progyny | Maintains: Buy | $31 → $24 | $21.63 | +10.96% | 4 | Sep 19, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $14 → $23 | $50.35 | -54.32% | 4 | Jun 27, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $19 → $23 | $18.38 | +25.14% | 4 | Jun 27, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $41 → $44 | $35.54 | +23.80% | 3 | Jun 7, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $17 | $18.43 | -7.76% | 1 | Dec 19, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Assumes: Buy | $230 | $146.93 | +56.54% | 1 | Dec 19, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $100 | $4.40 | +2,172.73% | 2 | Dec 15, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reinstates: Buy | $70 | $26.98 | +159.45% | 2 | Jul 25, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Hold | $55 | $24.35 | +125.87% | 1 | Oct 21, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $16 | $11.00 | +45.45% | 1 | Oct 21, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Assumes: Buy | $14 | $5.63 | +148.67% | 1 | Oct 21, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $78 → $46 | $72.67 | -36.70% | 2 | May 18, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $31 → $28 | $2.81 | +896.44% | 2 | Mar 17, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $70 | $23.28 | +200.69% | 1 | Dec 2, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Hold | $120 | $6.49 | +1,749.00% | 3 | Dec 2, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Hold | $2 | $2.54 | -21.26% | 1 | Dec 2, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $47 | $4.10 | +1,046.34% | 1 | Dec 2, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $36 | $4.09 | +780.20% | 1 | Dec 2, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $74.00 | - | 3 | Mar 17, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $173 → $169 | $692.24 | -75.59% | 5 | May 21, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $148.68 | - | 4 | Dec 16, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $79 → $82 | $67.37 | +21.72% | 2 | Apr 24, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Hold | $250 | $129.44 | +93.14% | 1 | Dec 8, 2017 |
HealthEquity
Sep 3, 2025
Maintains: Buy
Price Target: $130 → $134
Current: $92.28
Upside: +45.21%
Teladoc Health
Apr 21, 2025
Maintains: Hold
Price Target: $10 → $8
Current: $7.90
Upside: +1.27%
ANI Pharmaceuticals
Mar 14, 2025
Initiates: Buy
Price Target: $80
Current: $95.36
Upside: -16.10%
Viatris
Mar 7, 2025
Maintains: Buy
Price Target: $15 → $13
Current: $9.62
Upside: +35.14%
Waystar Holding
Feb 11, 2025
Initiates: Buy
Price Target: $51
Current: $38.59
Upside: +32.16%
Xeris Biopharma Holdings
Jan 29, 2025
Reiterates: Buy
Price Target: $4 → $6
Current: $7.67
Upside: -21.77%
Envista Holdings
Jan 23, 2025
Maintains: Hold
Price Target: $20 → $22
Current: $20.98
Upside: +4.86%
DENTSPLY SIRONA
Jan 23, 2025
Downgrades: Hold
Price Target: $30 → $20
Current: $13.43
Upside: +48.92%
Pacira BioSciences
Sep 24, 2024
Maintains: Buy
Price Target: $15 → $18
Current: $26.07
Upside: -30.96%
Progyny
Sep 19, 2024
Maintains: Buy
Price Target: $31 → $24
Current: $21.63
Upside: +10.96%
Jun 27, 2024
Maintains: Hold
Price Target: $14 → $23
Current: $50.35
Upside: -54.32%
Jun 27, 2024
Maintains: Buy
Price Target: $19 → $23
Current: $18.38
Upside: +25.14%
Jun 7, 2024
Upgrades: Buy
Price Target: $41 → $44
Current: $35.54
Upside: +23.80%
Dec 19, 2023
Initiates: Buy
Price Target: $17
Current: $18.43
Upside: -7.76%
Dec 19, 2023
Assumes: Buy
Price Target: $230
Current: $146.93
Upside: +56.54%
Dec 15, 2023
Reiterates: Buy
Price Target: $100
Current: $4.40
Upside: +2,172.73%
Jul 25, 2023
Reinstates: Buy
Price Target: $70
Current: $26.98
Upside: +159.45%
Oct 21, 2022
Initiates: Hold
Price Target: $55
Current: $24.35
Upside: +125.87%
Oct 21, 2022
Initiates: Buy
Price Target: $16
Current: $11.00
Upside: +45.45%
Oct 21, 2022
Assumes: Buy
Price Target: $14
Current: $5.63
Upside: +148.67%
May 18, 2022
Maintains: Buy
Price Target: $78 → $46
Current: $72.67
Upside: -36.70%
Mar 17, 2022
Upgrades: Buy
Price Target: $31 → $28
Current: $2.81
Upside: +896.44%
Dec 2, 2021
Initiates: Buy
Price Target: $70
Current: $23.28
Upside: +200.69%
Dec 2, 2021
Initiates: Hold
Price Target: $120
Current: $6.49
Upside: +1,749.00%
Dec 2, 2021
Initiates: Hold
Price Target: $2
Current: $2.54
Upside: -21.26%
Dec 2, 2021
Initiates: Buy
Price Target: $47
Current: $4.10
Upside: +1,046.34%
Dec 2, 2021
Initiates: Buy
Price Target: $36
Current: $4.09
Upside: +780.20%
Mar 17, 2021
Downgrades: Neutral
Price Target: n/a
Current: $74.00
Upside: -
May 21, 2020
Maintains: Hold
Price Target: $173 → $169
Current: $692.24
Upside: -75.59%
Dec 16, 2019
Downgrades: Neutral
Price Target: n/a
Current: $148.68
Upside: -
Apr 24, 2018
Maintains: Buy
Price Target: $79 → $82
Current: $67.37
Upside: +21.72%
Dec 8, 2017
Initiates: Hold
Price Target: $250
Current: $129.44
Upside: +93.14%